Purpose of the work - About 14% of adult/old horses naturally develop an asthma-like disease known as equine asthma1. Metabolomics is gaining popularity in human and veterinary medicine2,3. The metabolomic profile of exhaled breath condensate (EBC) and tracheal wash (TW) was investi- gated in horses4. In this study, we investigated the metabolomic profile of EBC and bronchoalveolar lavage fluid (BALF) in healthy and asthma-affected horses. Materials and used methods - On the basis of clinical, endoscopic findings and BALF cytology, 6 horses were included in asthma group (Group A), 6 horses were included in control group (Group C). BALF and EBC samples were collected as described previously4,5] and stored at -80°C until analy- sis by 1H-NMR6. The F-test was used for statistical analysis. Results - 1H-NMR identified 12 metabolites in BALF: formate, lactate, myo-inositol, glycerol, glycine, taurine, creatine, succinate, pyruvate, acetate, ethanol and isopropanol. Metabolites in EBC includ- ed methanol, ethanol, formate, trimethylamine, acetone, acetate and lactate. Among respiratory metabo- lites, myo-inositol, formate, glycerol and isopropanol in BALF, methanol and ethanol in EBC differed between groups (p<0.05). Conclusions - The analysis of BALF performed in this study completes the metabolomic profile of respiratory system4 in healthy and asthma-affected horses. In BALF, Group A had lower levels of myo- inositol, a metabolite that promotes maturation of pulmonary surfactant and supports respiratory func- tion7. In EBC, higher methanol was found in Group A, indicating an active inflammatory status4,8. Con- sidering our results, metabolomics has a great potential to better explain the pathophysiology of equine asthma, allowing researchers to adopt novel diagnostics and therapeutic strategies to treat the disease.
RESPIRATORY METABOLITES IN BRONCHOALVEOLAR LAVAGE FLUID (BALF) AND EXHALED BREATH CONDENSATE (EBC) OF HEALTHY HORSES AND HORSES AFFECTED BY EQUINE ASTHMA
Bazzano, Marilena;Magi, Gian Enrico;Serri, Evelina;Tesei Beniamino;Laus Fulvio
2019-01-01
Abstract
Purpose of the work - About 14% of adult/old horses naturally develop an asthma-like disease known as equine asthma1. Metabolomics is gaining popularity in human and veterinary medicine2,3. The metabolomic profile of exhaled breath condensate (EBC) and tracheal wash (TW) was investi- gated in horses4. In this study, we investigated the metabolomic profile of EBC and bronchoalveolar lavage fluid (BALF) in healthy and asthma-affected horses. Materials and used methods - On the basis of clinical, endoscopic findings and BALF cytology, 6 horses were included in asthma group (Group A), 6 horses were included in control group (Group C). BALF and EBC samples were collected as described previously4,5] and stored at -80°C until analy- sis by 1H-NMR6. The F-test was used for statistical analysis. Results - 1H-NMR identified 12 metabolites in BALF: formate, lactate, myo-inositol, glycerol, glycine, taurine, creatine, succinate, pyruvate, acetate, ethanol and isopropanol. Metabolites in EBC includ- ed methanol, ethanol, formate, trimethylamine, acetone, acetate and lactate. Among respiratory metabo- lites, myo-inositol, formate, glycerol and isopropanol in BALF, methanol and ethanol in EBC differed between groups (p<0.05). Conclusions - The analysis of BALF performed in this study completes the metabolomic profile of respiratory system4 in healthy and asthma-affected horses. In BALF, Group A had lower levels of myo- inositol, a metabolite that promotes maturation of pulmonary surfactant and supports respiratory func- tion7. In EBC, higher methanol was found in Group A, indicating an active inflammatory status4,8. Con- sidering our results, metabolomics has a great potential to better explain the pathophysiology of equine asthma, allowing researchers to adopt novel diagnostics and therapeutic strategies to treat the disease.File | Dimensione | Formato | |
---|---|---|---|
Bazzano Marilena 2019 Respiratory Metabolites in Bronchoalveolar Lavage Fluid.pdf
accesso aperto
Tipologia:
Versione Editoriale
Licenza:
DRM non definito
Dimensione
1.31 MB
Formato
Adobe PDF
|
1.31 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.